[ESPR] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
10-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 3.56%
YoY- 2.39%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -37,891 -28,956 -13,122 -9,457 -9,689 -2,775 -6,619 12.32%
Tax 807 423 287 135 47 476 692 1.02%
NP -37,891 -28,956 -13,122 -9,457 -9,689 -2,775 -6,619 12.32%
Tax Rate - - - - - - - -
Total Cost 37,891 28,956 13,122 9,457 9,689 2,775 6,619 12.32%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 CAGR
EPS -1.44 -1.28 -0.58 -0.49 -0.63 -0.29 -1.58 -0.61%
EPS Diluted -1.44 -1.28 -0.58 -0.49 -0.63 -0.29 -1.58 -0.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.